Vitamin C and HbA1c have become a growing area of interest for researchers and people managing diabetes alike. Vitamin C (ascorbic acid) is a well-established antioxidant micronutrient, whilst HbA1c is the key glycated haemoglobin marker used across the NHS to assess average blood glucose control over two to three months. Emerging clinical evidence suggests vitamin C may have a modest influence on HbA1c levels, though the relationship is not yet fully understood. This article explores the proposed mechanisms, what the clinical trials show, safe intake levels for people with diabetes in the UK, and when to seek advice from your GP or diabetes team.

How Vitamin C May Influence Blood Sugar and HbA1c Levels

Vitamin C may modestly support glycaemic regulation by reducing oxidative stress and potentially inhibiting non-enzymatic glycation of haemoglobin, though these mechanisms are based on laboratory and observational data rather than established clinical evidence.

Vitamin C (ascorbic acid) is a water-soluble micronutrient well known for its antioxidant properties and its role in immune function, collagen synthesis, and tissue repair. In recent years, researchers have begun exploring a potential relationship between vitamin C and HbA1c — the glycated haemoglobin marker used to assess average blood glucose levels over approximately two to three months. In the UK, HbA1c is reported in mmol/mol (with % equivalents sometimes cited in older or international literature).

Several mechanisms have been proposed, though all should be regarded as hypotheses rather than established clinical facts.

First, vitamin C's antioxidant capacity may help reduce oxidative stress, which is elevated in people with type 2 diabetes and is thought to impair insulin signalling. By neutralising reactive oxygen species, ascorbate may support more effective insulin action at the cellular level, potentially contributing to modest improvements in glycaemic regulation over time.

Second, some researchers have suggested that ascorbate may directly inhibit non-enzymatic protein glycation — the chemical process by which glucose attaches to haemoglobin to form HbA1c. This remains an area of active investigation, and the clinical significance of any such effect is uncertain.

It is important to note that HbA1c primarily reflects ambient plasma glucose concentrations and red blood cell lifespan; vitamin C does not reduce glucose entry into red blood cells. Ascorbic acid is transported into cells via sodium-dependent vitamin C transporters (SVCTs), not the glucose transporters (GLUTs) used by glucose. Only the oxidised form, dehydroascorbic acid, uses GLUT transporters, and this does not meaningfully reduce red-cell glucose influx under normal physiological conditions.

Overall, these mechanisms are largely based on laboratory and observational data. The relationship between vitamin C and HbA1c is not yet fully established in clinical practice, and vitamin C supplementation is not currently recommended by NICE (NG28) as a treatment for diabetes or poor glycaemic control. Any potential benefit should be considered within the broader context of a balanced diet and evidence-based diabetes management.

What the Clinical Evidence Says About Vitamin C and HbA1c

Meta-analyses suggest vitamin C supplementation produces small, statistically significant reductions in HbA1c (approximately 4–6 mmol/mol) in type 2 diabetes, but evidence is limited by heterogeneity, small sample sizes, and lack of long-term safety data.

A growing body of clinical research has examined whether vitamin C supplementation can meaningfully reduce HbA1c levels in people with type 2 diabetes. Several randomised controlled trials and meta-analyses have reported modest but statistically significant reductions in HbA1c following supplementation, typically at doses ranging from 500 mg to 1,000 mg per day over periods of several weeks to months.

A meta-analysis published in Nutrients (Ellulu et al. and subsequent pooled analyses) found that vitamin C supplementation was associated with a small reduction in HbA1c — in the region of 0.4–0.5 percentage points (approximately 4–6 mmol/mol) — alongside modest improvements in fasting blood glucose and blood pressure in individuals with type 2 diabetes. However, the authors acknowledged important limitations, including:

• Heterogeneity across studies in terms of dosage, duration, and participant characteristics

• Small sample sizes in many individual trials

• Variability in baseline vitamin C status among participants

• Lack of long-term safety data for high-dose supplementation

Some researchers have raised a methodological concern: vitamin C may interfere with certain laboratory assays used to measure HbA1c. However, most NHS laboratories in the UK use IFCC-standardised, NGSP-certified methods (such as HPLC or immunoassay), which show minimal interference from ascorbate at physiological or typical supplementation concentrations. Observed reductions in HbA1c in some studies are therefore more likely to reflect a genuine, if modest, biological effect rather than a purely analytical artefact — though this remains an area of ongoing scientific debate.

A separate practical concern applies to people using continuous glucose monitoring (CGM) or flash glucose monitoring systems (such as the Abbott FreeStyle Libre). High-dose vitamin C supplementation can cause some sensor-based systems to over-read glucose levels. Patients using these devices should check the manufacturer's UK user guide for specific guidance on vitamin C and sensor accuracy.

Overall, while the evidence is promising, it remains insufficient to support routine vitamin C supplementation as a strategy for lowering HbA1c. Current NICE guidelines (NG28) for type 2 diabetes management focus on lifestyle modification, structured education programmes, and pharmacological therapy where appropriate, rather than micronutrient supplementation.

Recommended Vitamin C Intake for People with Diabetes in the UK

The UK RNI for vitamin C is 40 mg per day for adults; no higher intake is endorsed by NICE or the NHS for people with diabetes, and supplementation above 1,000 mg per day is not recommended.

In the UK, the Reference Nutrient Intake (RNI) for vitamin C in adults is 40 mg per day, as established by the Department of Health and Social Care. This level is considered sufficient to prevent deficiency in most healthy adults. The NHS advises that most people can meet this requirement through a varied and balanced diet rich in fruits and vegetables, without the need for supplementation.

For people with diabetes, there is currently no separate, higher recommended intake endorsed by NICE or the NHS. Some nutrition researchers suggest that individuals with diabetes may have increased oxidative stress and potentially higher vitamin C requirements, and that poorly controlled diabetes may be associated with lower circulating vitamin C levels due to increased urinary excretion and greater metabolic demand. However, this remains unproven, and no authoritative UK body has issued a revised recommendation on this basis.

If supplementation is being considered, the NHS advises that taking less than 1,000 mg of vitamin C per day is unlikely to cause harm for most adults. High doses can cause:

• Gastrointestinal discomfort, including diarrhoea and nausea

• Increased risk of kidney stones, particularly oxalate stones in those who are predisposed or have a history of kidney stones — the NHS recommends that people at risk of kidney stones avoid high-dose vitamin C supplements

• Potential interference with readings on some CGM/flash glucose sensors — check your device's UK user guide

People with haemochromatosis (iron overload) should be aware that vitamin C increases iron absorption and should seek medical advice before taking supplements, in line with NHS guidance.

People with diabetes who are considering vitamin C supplements should always discuss this with their GP or diabetes care team first, particularly if they have kidney disease, are taking other medications, or have any other relevant health conditions. If you experience any suspected side effects from a supplement, you can report these to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk). Self-supplementing without professional guidance is not recommended.

Dietary Sources of Vitamin C and Their Role in Glycaemic Control

Bell peppers, broccoli, kiwi fruit, and strawberries are excellent low-GI dietary sources of vitamin C that support metabolic health without adversely affecting blood glucose levels.

Obtaining vitamin C through whole foods rather than supplements is generally preferred, as dietary sources provide a broader range of nutrients, fibre, and phytochemicals that collectively support metabolic health. For people with diabetes, food-based vitamin C intake is particularly advantageous because many vitamin C-rich foods also have a low glycaemic index (GI), meaning they cause a slower, more gradual rise in blood glucose.

Good dietary sources of vitamin C include:

• Citrus fruits (oranges, grapefruits, lemons) — a portion is typically one medium fruit (approximately 80 g); whole fruit is preferable to juice, as fruit juices and smoothies can cause a more rapid rise in blood glucose and should be limited

• Kiwi fruit — one of the richest sources per gram

• Strawberries and blackcurrants — widely available in the UK and relatively low in sugar

• Bell peppers (red and yellow) — exceptionally high in vitamin C and low in carbohydrates

• Broccoli, Brussels sprouts, and cabbage — excellent sources with minimal impact on blood glucose

• Tomatoes and tomato-based products — versatile and widely consumed; when choosing tinned or jarred tomato products, check the label for added sugars or salt

Vegetables such as broccoli and peppers are particularly beneficial for people managing diabetes, as they combine high vitamin C content with dietary fibre, which slows glucose absorption and supports satiety. The NHS Eatwell Guide encourages at least five portions of fruit and vegetables per day (each portion approximately 80 g), and for people with diabetes, prioritising non-starchy vegetables is a practical way to boost vitamin C intake without adversely affecting glycaemic control. Diabetes UK also advises that all types of fruit and vegetables can be included as part of a healthy diet for people with diabetes, with attention to portion sizes for higher-sugar fruits.

It is worth noting that vitamin C is heat-sensitive and water-soluble, meaning cooking methods can significantly affect its content. Steaming or lightly stir-frying vegetables, rather than boiling, helps preserve more of the nutrient. Eating some vitamin C-rich foods raw, where appropriate, is also a simple strategy to maximise intake.

When to Speak to Your GP or Diabetes Team About Vitamin C

Seek GP or diabetes team advice before supplementing with vitamin C if you have kidney disease, kidney stones, haemochromatosis, or take warfarin or chemotherapy, or if your HbA1c results are inconsistent with your glucose monitoring readings.

Whilst vitamin C is generally considered safe and well tolerated, there are specific circumstances in which people with diabetes should seek professional advice before making changes to their intake or starting supplementation. Open communication with your GP or diabetes care team is always the safest approach when considering any dietary or supplement change.

You should speak to your GP or diabetes team if:

• Your HbA1c results (reported in mmol/mol in the UK) are unexpectedly low or inconsistent with your home blood glucose or CGM/flash sensor readings — whilst most UK laboratory methods are not significantly affected by vitamin C at typical doses, high-dose supplementation may affect some sensor-based glucose monitoring systems; check your device's UK user guide for specific advice

• You are considering taking vitamin C supplements at doses above 500 mg per day, particularly if you have kidney disease, a history of kidney stones, haemochromatosis, or are taking other medications

• You are taking anticoagulants such as warfarin, or are receiving antineoplastic (chemotherapy) therapy — consult your clinical team and check the BNF or your medication's summary of product characteristics (SmPC) before starting any supplement, as interactions may be clinically relevant in some contexts

• You have noticed symptoms that may suggest vitamin C deficiency, such as fatigue, easy bruising, slow wound healing, or bleeding gums — these can also be associated with poorly controlled diabetes and warrant proper assessment

• You are pregnant or breastfeeding and have diabetes, as nutritional requirements differ during these periods

It is also worth raising the topic of vitamin C if you follow a restricted diet — for example, due to food allergies, eating difficulties, or financial constraints — as these situations may increase the risk of inadequate intake. Your diabetes team or a registered dietitian can provide personalised dietary advice tailored to your health needs and treatment plan.

If you develop severe loin or flank pain, fever, or notice blood in your urine, seek urgent assessment via NHS 111 or your nearest urgent care service, as these may be symptoms of a kidney stone requiring prompt evaluation.

If you experience any suspected side effects from a vitamin C supplement, report them to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Experiencing these side effects? Our pharmacists can help you navigate them →

In summary, while the relationship between vitamin C and HbA1c is an area of genuine scientific interest, it remains an evolving field. Vitamin C should be viewed as one component of a healthy, balanced diet rather than a standalone intervention for glycaemic management. Always work with your healthcare team to make informed, evidence-based decisions about your diabetes care.

Frequently Asked Questions